FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/12/2023
Voltar para busca
Dado oficial do USPTO
GP GETEIN BIOTECH, INC.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
11/12/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
17/11/2021
Data de registro
22/08/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/08/2023
Última transação
22/08/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CN
Examinador
KLUWE, CHERYL D
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "GP GETEIN BIOTECH, INC.", "GP" formed by horizontal lines and appearing to the left of "GETEIN BIOTECH, INC.".
Titulares e representantes
Titulares
Getein Biotech, Inc.
Representantes
Timothy T. Wang NI, WANG & MASSAND, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for human purposesmedicines for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; biological preparations for medical purposespreparations for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical usepreparations for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; Medicated serums for treatment of viral infectionsdiseases of the blood systemdiseases of the immune systemskin diseasesdiseases caused by bacterial exotoxinsbacterial infectionsfungal infectionsparasitic infections; chemical preparations for medical purposesfor cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; vaccines; dietetic substances adapted for medical use
Classe 10
Diagnostic testing apparatus for testing blood sugar levelscancer cellsDNAsugarshormonesenzymeslipidsvitaminsinorganic ionselectrolytesdrugs and drug metabolitesautoantibodiesproteinsmicroorganismsDrug allergyallergensantigens of pathogenic pathogensantibodies of pathogenic pathogens and nucleic acids of pathogenic pathogensblood typetissue typehuman geneshereditary diseasesbiochemical indicatorsimmune function indicatorsnarcoticspsychotropic drugsToxic drugs for medical usetherapeutic drug targetstumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levelscancer cellsDNAsugarshormonesenzymeslipidsvitaminsinorganic ionselectrolytesdrugs and drug metabolitesautoantibodiesproteinsmicroorganismsDrug allergyallergensantigens of pathogenic pathogensantibodies of pathogenic pathogens and nucleic acids of pathogenic pathogensblood typetissue typehuman geneshereditary diseasesbiochemical indicatorsimmune function indicatorsnarcoticspsychotropic drugsToxic drugs for medical usetherapeutic drug targetstumor markers; Medical apparatus and instrumentsfor cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases diagnosis; urological apparatus and instruments for surgerydiagnostic testingtreatmentadjuvant therapy; X-ray apparatus for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/11/2023
FIMP
FINAL DISPOSITION PROCESSED
22/11/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/11/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
22/08/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/04/2023
RFNT
REFUSAL PROCESSED BY IB
21/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/11/2022
RFRR
REFUSAL PROCESSED BY MPU
03/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/09/2022
CNRT
NON-FINAL ACTION WRITTEN
09/09/2022
DOCK
ASSIGNED TO EXAMINER
29/08/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GP GETEIN BIOTECH, INC. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.